Related Experiment Video
Updated: Jul 15, 2026
08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
A strategy for making synthetic peptide vaccines
K Ogasawara1, H Naruse, Y Itoh
1Section of Pathology, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
Summary
Researchers identified key amino acid sites on synthetic peptides for immune responses. This led to the development of effective influenza Aichi peptide vaccines that stimulate T-cells and antibodies without major histocompatibility complex binding side effects.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Understanding the interaction between peptide antigens and major histocompatibility complex (MHC) class II molecules is crucial for vaccine development.
- The agretope and epitope regions of a peptide antigen play distinct roles in T-cell recognition and MHC binding.
Purpose of the Study:
- To determine the H-2 class II allele-specific amino acid motif of the agretope for a synthetic peptide (p43-58).
- To design and evaluate novel synthetic peptide vaccines targeting influenza Aichi (H3N2) virus.
Main Methods:
- Defined the agretope (residues 46 and 54) and epitope (residues 50 and 52) of pigeon cytochrome c peptide (p43-58).
- Synthesized peptide analogues incorporating influenza Aichi hemagglutinin residues into the p43-58 frame.
- Administered these peptide vaccines to mice with specific H-2 class II alleles (Ak or Ab).
Main Results:
- The synthetic peptide vaccines elicited helper T-cell responses and specific antibodies against influenza Aichi hemagglutinin.
- Antibody production was specific to the viral hemagglutinin and not the MHC binding frame.
- The induced antibodies demonstrated in vitro neutralization of influenza Aichi infectivity.
Conclusions:
- Agretopes and epitopes function independently, allowing for targeted vaccine design.
- These findings support the development of potent and specific peptide vaccines with reduced side effects.
- This approach offers a promising strategy for creating next-generation vaccines against viral pathogens.
